Edition:
United Kingdom

Rockwell Medical Inc (RMTI.OQ)

RMTI.OQ on NASDAQ Stock Exchange Global Market

2.38USD
22 Aug 2019
Change (% chg)

-- (--)
Prev Close
$2.38
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
115,059
52-wk High
$6.88
52-wk Low
$2.19

Latest Key Developments (Source: Significant Developments)

Rockwell Medical Says Q2 Loss Per Share $0.18
Thursday, 8 Aug 2019 

Aug 8 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL, INC. REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.18.Q2 SALES $14.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $16.4 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $-0.17 -- REFINITIV IBES DATA.AS OF JUNE 30, 2019, COMPANY HAD CASH, CASH EQUIVALENTS AND INVESTMENTS AVAILABLE-FOR-SALE OF $35.2 MILLION.  Full Article

Rockwell Medical Announces Acceptance By FDA Of New Drug Application For I.V. Triferic
Tuesday, 6 Aug 2019 

Aug 6 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL, INC. ANNOUNCES ACCEPTANCE BY FDA OF NEW DRUG APPLICATION FOR I.V. TRIFERIC®.ROCKWELL MEDICAL - FDA ACCEPTED FOR FILING NDA FOR INTRAVENOUS FORMULATION OF TRIFERIC WITH A PDUFA DATE OF MARCH 28, 2020.  Full Article

Rockwell Medical Announces Pricing Of $17.5 Million Public Offering Of Common Stock
Tuesday, 18 Jun 2019 

June 18 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL ANNOUNCES PRICING OF $17.5 MILLION PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 5.83 MILLION COMMON SHARES PRICED AT $3.00PER SHARE.  Full Article

Rockwell Medical Q1 Loss Per Share $0.15
Thursday, 9 May 2019 

May 9 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL, INC. REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.15.Q1 SALES ROSE 4 PERCENT TO $15.6 MILLION.AS OF MARCH 31, 2019, COMPANY HAD CASH, CASH EQUIVALENTS AND INVESTMENTS AVAILABLE-FOR-SALE OF $27.8 MILLION.CASH USED IN OPERATING ACTIVITIES FOR Q1 OF 2019 WAS $5.4 MILLION..  Full Article

Rockwell Medical Files For Offering Of Shares Of Up To $40 Mln Through Cantor Fitzgerald As Sales Agent
Friday, 22 Mar 2019 

March 22 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL INC - FILES FOR OFFERING, TO OFFER AND SELL SHARES OF COMMON STOCK OF UP TO $40 MILLION THROUGH CANTOR FITZGERALD AS SALES AGENT.  Full Article

Rockwell Medical Files Prospectus Relating To Resale By Selling Shareholder
Friday, 16 Nov 2018 

Nov 16 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL FILES PROSPECTUS RELATING TO RESALE BY SELLING SHAREHOLDER OF UP TO 8.3 MILLION SHARES OF COMMON STOCK - SEC FILING.  Full Article

Rockwell Medical Expects To File IV Triferi Nda In Q4
Friday, 12 Oct 2018 

Oct 12 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL PROVIDES UPDATE ON IV TRIFERIC.ROCKWELL MEDICAL INC - IN PROCESS OF PREPARING A NEW DRUG APPLICATION ("NDA") FOR IV TRIFERIC.ROCKWELL MEDICAL INC - ANTICIPATES THAT IT WILL FILE NDA IN Q4 OF 2018 FOR IV TRIFERIC.ROCKWELL MEDICAL INC - ANTICIPATES WILL FILE NDA IN Q4 OF 2018 FOR IV TRIFERIC WHICH WOULD RESULT IN A PDUFA ACTION DATE IN LATE 2019.ROCKWELL MEDICAL INC - RECENTLY CLARIFIED AND EXTENDED ADDITIONAL INTELLECTUAL PROPERTY RIGHTS RELATED TO IV TRIFERIC.  Full Article

Rockwell Medical Files Suit In Federal Court Against Former CEO Chioini, Former CFO Klema, Board Member Boyd And Former Board Member Bagley
Monday, 2 Jul 2018 

July 2 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL PROVIDES INVESTOR UPDATE.ROCKWELL MEDICAL - FILES SUIT IN FEDERAL COURT AGAINST FORMER CEO CHIOINI, FORMER CFO KLEMA, BOARD MEMBER BOYD AND FORMER BOARD MEMBER BAGLEY.ROCKWELL MEDICAL - LAWSUIT OUTLINES TIMING AND RATIONALE FOR BOARD'S DECISION TO TERMINATE CHIOINI AND KLEMA.  Full Article

Richmond Brothers Says Support Decision Made By Rockwell Medical
Friday, 25 May 2018 

May 25 (Reuters) - Rockwell Medical Inc ::RICHMOND BROTHERS SAYS FULLY SUPPORT DECISION MADE BY ROCKWELL MEDICAL’S BOARD TO TERMINATE ROBERT CHIOINI FROM POSITIONS PRESIDENT & CEO.RICHMOND BROTHERS SAYS ON MAY 24, DELIVERED LETTER TO ROCKWELL MEDICAL BOARD.RICHMOND BROTHERS SAYS BENEFICIALLY OWNS ABOUT 10.9% OF OUTSTANDING SHARES OF ROCKWELL MEDICAL.RICHMOND BROTHERS SAYS SUPPORT TERMINATION OF CFO THOMAS KLEMA’S POSITIONS WITH ROCKWELL MEDICAL - SEC FILING.  Full Article

Rockwell Medical Says CEO Robert Chioini Terminated From Post, Effective Immediately
Thursday, 24 May 2018 

May 24 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL ISSUES STATEMENT.ROCKWELL MEDICAL INC - COMPANY'S PRESIDENT AND CHIEF EXECUTIVE OFFICER, ROBERT CHIOINI, HAD BEEN TERMINATED FROM HIS POSITIONS, EFFECTIVE IMMEDIATELY.ROCKWELL MEDICAL - DECISION TO TERMINATE CHIOINI FOLLOWS A THOROUGH REVIEW OF BUSINESS, INCLUDING AN EVALUATION OF MANAGEMENT.ROCKWELL MEDICAL - MAJORITY OF DIRECTORS DETERMINED CHIOINI "LACKED KEY ATTRIBUTES" NECESSARY TO OVERSEE GROWTH AND LONG-TERM SUCCESS OF CO.ROCKWELL MEDICAL - DESPITE DULY AUTHORIZED TERMINATION BY BOARD, CHIOINI REFUSES TO ACCEPT DECISION.ROCKWELL MEDICAL - CHIOINI TAKEN ACTION PURPORTEDLY ON COMPANY'S BEHALF WITHOUT AUTHORIZATION TO DO SO.ROCKWELL MEDICAL - CHIOINI, CFO THOMAS KLEMA FILED FORM 8-K ON MAY 23 MAKING ASSERTIONS ON 5 INDEPENDENT DIRECTORS WHO VOTED IN FAVOR OF CHIOINI'S REMOVAL.ROCKWELL MEDICAL - WHILE ASSERTIONS IN FILING ARE UNRELATED TO BOARD'S REMOVAL OF CHIOINI, BOARD ACKNOWLEDGES RECEIPT OF PUTATIVE SHAREHOLDER DEMAND LETTER.ROCKWELL MEDICAL INC - PUTATIVE SHAREHOLDER DEMAND LETTER RAISES SUBSTANTIALLY SIMILAR ALLEGATIONS AS THOSE RAISED PERSONALLY BY CHIOINI.ROCKWELL MEDICAL - DUE TO CONDUCT OF KLEMA AFTER TERMINATION OF CHIOINI, 5 INDEPENDENT BOARD DIRECTORS AGREED ON NEED TO REMOVE KLEMA FROM HIS ROLES AT CO.ROCKWELL MEDICAL INC - NOTES THAT NASDAQ HAS REQUESTED ADDITIONAL INFORMATION REGARDING TWO FORM 8-K FILINGS FILED ON MAY 23, 2018.  Full Article